AXXAM

Grants

Axxam is the proud recipient of a significant number of grants and awards from agencies at the local, national and international levels. These grants and awards contribute to our continuing investment in research and development for drug discovery and other life sciences applications, thus recognizing our contribution to technological innovation and new products development.

Active projects

Italian Ministry of Economic Development (MISE) – Innovation Agreements
Title: AICos – Development of an in vitro assay platform for the identification of new pharmacological compounds for the treatment of rare neurodegenerative diseases, with a particular focus on ALS
Start: February 2023

Italian Presidency of the Council of Ministers – Department for family policies
Title: Evolu-ACTION – The evolution of the Person as a driving force for the evolution of the Company
(Original title: Evolu-AZIONE: L’evoluzione della Persona come volano per l’evoluzione dell’Azienda)
Start: April 2022

European Commission – Horizon 2020-Innovative Medicines Initiative 2 (IMI2):
Title: REsolution – Add medical genetic solutions to RESOLUTE
Start: June 2021

European Commission – Horizon 2020-Innovative Medicines Initiative 2 (IMI2):
Title: ReSolute – Research empowerment on solute carriers
Start: July 2018

Completed projects

Lombardy Region – POR FESR 2014-2020 – Call «Tech Fast Lombardia»
Title: MiDA – Mitochondrial Disfunction Assays
Term: January 2022 – January 2023

European Commission – Horizon 2020-Innovative Medicines Initiative 2 (IMI2)
Title: PHAGO – Inflammation and AD: modulating microglia function – focussing on TREM2 and CD33
Term: November 2016 – April 2022

Italian Ministry of Research (MIUR) – PON 2014-2020
Title: PerMedNet – Personalized Medicine for Innovative Strategies in Neuropsychiatric and vascular diseases
Start: May 2018 – October 2021

Ministry of Economic Development – FCS – Research & Development Big Projects – PON
Title: Q-RARE – Integrated technological platform for the identification and development of new drugs for the treatment of rare diseases or high dissatisfied need of care
Term: November 2017 – October 2021

Innovation Fund Denmark (IFD) – Grand Solutions 2018
Title: HB-086 – HB-086 (hMeteorin), an innovative biopharmaceutical development candidate for neuropathic pain
Start: September 2018 – December 2020

Lombardy Region – POR FESR 2014-2020
Title: STOP-COV – A Lombard preclinical and translational research Task Force to tackle the coronavirus
Term: April 2020 – October 2020

Lombardy Region – POR FESR 2014-2020
Title: iPSLight – New iPSC biotechnological systems for pharmaceutical development in the field of neurodegenerative diseases
Term: February 2017 – April 2020

European Commission – Horizon 2020-Innovative Medicines Initiative 2 (IMI2)
Title: NGN-PET – Modelling Neuron-Glia Networks into a drug discovery platform for Pain Efficacious Treatments
Term: April 2017 – March 2020

Italian Ministry of Economic Development (MISE) – EuroTransBio
Title: NeurOptics – Development of iPSCs derived Opto-neurons suitable for high-throughput screening (HTS)
Term: January 2017 – December 2019

European Commission – Italian Ministry of Research (MIUR) – Horizon 2020- Eurostars 2
Title: Chem2Bio – A novel structure based discovery platform to translate orphan GPCR into new drug targets
Term: November 2017 – October 2019

Lombardy Region – POR FESR 2014-2020
Title: COGNIPLANT – New botanical products for the prevention of cognitive deficits in the adult age and aging phase
Term: December 2016 – June 2019

Alzheimer’s Drug Discovery Foundation (ADDF)
Title: Exploratory Optimization of New CX3CR1 modulators for the treatment of AD
Term: September 2017- August 2018

Italian Ministry of Economic Development (MISE) – EuroTransBio
Title: OPTEL – A novel optogenetic electrophysiology platform for ion channel and transporter screening
Term: December 2015 – November 2017

Italian Ministry of Research (MIUR) – National Technological Cluster Life Sciences (ALISEI)
Title: Cutting-edge technologies to increase safety and efficacy of drugs and vaccines (MEDINTECH)
Term: January 2014 – December 2016

European Commission – Seventh Framework Program
Title: Satiety Innovation (SATIN – www.satin-satiety.eu)
Term: January 2012 – December 2016
SATIN poster available on demand

EUREKA – Italian Ministry of Research (MIUR), Eurostars Programme – X Call
Title: Novel therapeutic approaches to combat obesity pandemic and its sequel (Hypo greedy)
Term: September 2013 – August 2016

Alzheimer’s Drug Discovery Foundation (ADDF)
Title: Optimization of P2X7 antagonists for AD treatment
Term: December 2015 – July 2016

European Commission – Seventh Framework Program
Title: From sea-bed to test-bed: harvesting the potential of marine biodiversity for industrial biotechnology (SeaBioTech)
Term: August 2012 – July 2016

EUREKA – Italian Ministry of Research (MIUR), Eurostars Programme – VIII Call
Title: Novel therapeutic approaches for resolution of inflammation (ChemExit)
Term: December 2012 – May 2016

Campania Region – POR – FESR
Title: TIMING – Innovative Therapies of chronic inflammatory, metabolic, neoplastic and geriatric diseases
Term: August 2013 – December 2015

Campania Region – POR – FESR
Title: OCKey – Oncology and Cardiology Key Targets
Term: August 2013 – December 2015

Italian Ministry of Research (MIUR) – PON Program
Title: An integrated technological platform for the development of new drugs for rare diseases (PON1_00862)
Term: July 2011 – December 2015

Lombardy Region and Italian Ministry of Research (MIUR)
Title: OMICS (Optical Method for Ion Channel Screening)
Term: December 2011 – March 2015

EUREKA – Italian Ministry of Research (MIUR), Eurostars Programme – V Call
Title: Innovative GLP-1R modulators for Type-2 Diabetes treatment (InsuSecret)
Term: July 2011 – December 2014

Ministry of Economic Development – EuroTransBio
Title: NeuroSafe – Neurotoxicity Safety Platform
Term: November 2012 – October 2014

Lombardy Region – FRIM – FESR 2011
Title: Cardiac Safety Panel (CaSP)
Term: February 2013 – July 2014

Lombardy Region – FRIM 2011
Title: Systems for Quality Control and automated management of chemical libraries for HTS
Term: February 2013 – July 2013

Fast Forward LLC and MERCK KGaA
Title: Chloride Channel blockers discovery program for inflammatory microglia suppression (CLIC1)
Term: January 2012 – December 2012

Lombardy Region – ATP 2009
Title: Identification of GOAT inhibitors (SLIMGOAT)
Term: June 2010 – December 2012

Fast Forward & MERCK KGaA
Title: Small Molecule NCX1 blockers for axonal survival in Multiple Sclerosis
Term: May 2011 – October 2012

Fast Forward LLC and Juvenile Diabetes Research Foundation (JDRF)
Title: Discovery research of innovative immunosuppressant for prevention of type 1 diabetes
Term: June 2011 – July 2012

Alzheimer’s Drug Discovery Foundation (ADDF)
Title: Small Molecule P2X7 Antagonists for AD treatment
Term: May 2011 – April 2012

Lombardy Region – Proceeded Innovation and Services Organization
Title: Frozen cells in HTS (Forzen4Array)
Term: November 2010 – April 2012

EUREKA – Italian Ministry of Research (MIUR), Eurostars Programme – III Call
Title: Identification of ICRAC antagonists (ICRAC)
Term: June 2010 – May 2012

European Commission – Seventh Framework Program
Title: Neuron – glia interactions in health and disease (NGIDD)
Term: April 2008 – March 2012

European Commission – Sixth Framework Program
Title: Production of innovative biomedical drugs (CONCO)
Term: February 2007 – January 2012

Lombardy Region – GrantMetadistretti 2008
Title: From the molecular target to therapy: a drug discovery integrated process for innovative pain treatments (NaVs for Pain)
Term: November 2008 – November 2011

Italian Ministry of Foreign Affairs (MAE), Italian Ministry of Research (MIUR) and Korean Ministry of Education, Science and Technology (MEST) Law 401/90 – Bilateral projects
Title: Bioactive compounds for the valorization and promotion of traditional food
Term: January 2010 – December 2010

Fast Forward LLC and Juvenile Diabetes Research Foundation (JDRF) – Sponsored Research Agreement
Title: Identification of Kv1.3 blockers for treatment of Type1 diabetes and Multiple Sclerosis
Term: July 2009 – December 2010

European Commission – Sixth Framework Program
Title: Development of clinical diagnostic tools in atherosclerosis (SOUTH)
Term: October 2006 – March 2010

Italian Ministry of Research (MIUR) and Region of Lombardy Law 593/2000 art.12
Title: Identification and characterization of GPCRs (G protein – coupled receptors) inhibitors
Term: March 2006 – December 2009

European Commission – Sixth Framework Program
Title: Targeting Cell Migration In Chronic Inflammation (MAIN)
Term: September 2007 – December 2008

Lombardy Region – Metadistretti 2005
Title: Identification and characterization of chemokine receptors
Term: July 2006 – December 2008

Italian Ministry of Research (MIUR) and Sardinia Region – Law 593/2000 art.13 (Lab. 5)
Title: Development of methodologies for the modeling and the study of biodrugs
Term: January 2006 – December 2008

Italian Ministry of Productive Activities (MAP) – Law 1982/46 – Lombardy FIT
Title: Novel targets identification
Term: September 2004 – August 2008

Italian Ministry of Research (MIUR) – Law 593/2000 art.10
Title: Drug discovery technologies
Term: September 2003 – August 2007

Lombardy Region – Metadistretti 2003
Title: Application of mouse embryonic stem cells in HTS
Term: January 2005 – July 2007

Scroll to Top